Free Trial

VectivBio (VECT) Competitors

VectivBio logo
$16.85 0.00 (0.00%)
As of 05/29/2026

VECT vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy VectivBio stock or one of its competitors? MarketBeat compares VectivBio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with VectivBio include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does VectivBio compare to Ainos?

VectivBio (NASDAQ:VECT) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

In the previous week, Ainos had 2 more articles in the media than VectivBio. MarketBeat recorded 2 mentions for Ainos and 0 mentions for VectivBio. Ainos' average media sentiment score of 0.44 beat VectivBio's score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company Overall Sentiment
VectivBio Neutral
Ainos Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VectivBioN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
VectivBioN/A N/A N/A
Ainos N/A N/A N/A

Summary

Ainos beats VectivBio on 3 of the 3 factors compared between the two stocks.

How does VectivBio compare to Alvotech?

VectivBio (NASDAQ:VECT) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
VectivBioN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Alvotech had 2 more articles in the media than VectivBio. MarketBeat recorded 2 mentions for Alvotech and 0 mentions for VectivBio. Alvotech's average media sentiment score of 1.44 beat VectivBio's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company Overall Sentiment
VectivBio Neutral
Alvotech Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VectivBioN/AN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

Summary

Alvotech beats VectivBio on 3 of the 3 factors compared between the two stocks.

How does VectivBio compare to Aravive?

VectivBio (NASDAQ:VECT) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
VectivBioN/A N/A N/A
Aravive N/A N/A N/A

In the previous week, VectivBio's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
VectivBio Neutral
Aravive Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VectivBioN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

35.8% of Aravive shares are owned by institutional investors. 9.7% of VectivBio shares are owned by insiders. Comparatively, 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Aravive beats VectivBio on 2 of the 2 factors compared between the two stocks.

How does VectivBio compare to Atlantic Coastal Acquisition Corp. II?

VectivBio (NASDAQ:VECT) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VectivBioN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
VectivBioN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

In the previous week, VectivBio's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
VectivBio Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

VectivBio and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does VectivBio compare to Biofrontera?

VectivBio (NASDAQ:VECT) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

Company Net Margins Return on Equity Return on Assets
VectivBioN/A N/A N/A
Biofrontera N/A N/A N/A

In the previous week, Biofrontera had 2 more articles in the media than VectivBio. MarketBeat recorded 2 mentions for Biofrontera and 0 mentions for VectivBio. Biofrontera's average media sentiment score of 0.43 beat VectivBio's score of 0.00 indicating that Biofrontera is being referred to more favorably in the news media.

Company Overall Sentiment
VectivBio Neutral
Biofrontera Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VectivBioN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Summary

Biofrontera beats VectivBio on 3 of the 3 factors compared between the two stocks.

Get VectivBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VECT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VECT vs. The Competition

MetricVectivBioMED IndustryMedical SectorNASDAQ Exchange
Market CapN/A$3.41B$6.43B$12.59B
Dividend YieldN/A2.29%2.69%5.33%
P/E RatioN/A18.8821.6326.26
Price / SalesN/A335.79565.57116.53
Price / CashN/A121.8843.2256.84
Price / BookN/A7.1210.557.30
Net IncomeN/A$24.20M$3.56B$337.27M
7 Day PerformanceN/A4.11%2.86%3.58%
1 Month PerformanceN/A6.66%4.59%5.71%
1 Year PerformanceN/A66.32%37.68%39.75%

VectivBio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VECT
VectivBio
N/A$16.85
flat
N/AN/A$0.00N/AN/A30
AIMDW
Ainos
N/A$0.06
-13.3%
N/A-16.1%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.19
-5.1%
N/A-87.3%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15

Related Companies and Tools


This page (NASDAQ:VECT) was last updated on 5/30/2026 by MarketBeat.com Staff.
From Our Partners